| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jolanda Howe | Ctrl;SVP | 2026-09-02 | 658 | $100.00 | $65.80kSell |
| Christopher Peetz | CEO | 2026-09-01 | 30,000 | $2.94 | $88.08kBuy |
| Christopher Peetz | CEO | 2026-09-01 | 8,312 | $98.08 | $815.24kSell |
| Christopher Peetz | CEO | 2026-09-01 | 21,688 | $98.91 | $2.15MSell |
| Jolanda Howe | Ctrl;SVP | 2026-08-18 | 40,000 | $6.27 | $250.80kBuy |
| Jolanda Howe | Ctrl;SVP | 2026-08-18 | 40,000 | $100.00 | $4.00MSell |
| Eric Bjerkholt | CFO | 2026-08-11 | 6,001 | $99.90 | $599.51kSell |
| Christopher Peetz | CEO | 2026-08-10 | 6,017 | $99.25 | $597.19kSell |
| Christopher Peetz | CEO | 2026-08-10 | 11,683 | $98.51 | $1.15MSell |
| Christopher Peetz | CEO | 2026-08-10 | 20,000 | $2.94 | $58.72kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joshua Makower | 6.45% | 4,186,243 | $422.39M | Insider |
| Peter J. Barris | 6.45% | 4,186,243 | $422.39M | Insider |
| Peter W. Sonsini | 6.45% | 4,186,243 | $422.39M | Insider |
| David M. Mott | 6.45% | 4,186,243 | $422.39M | Insider |
| Patrick J. Heron | 6.21% | 4,031,625 | $406.79M | Insider |
| Frazier Life Sciences IX LP | 5.49% | 3,566,912 | $359.90M | Insider |
| James E. Flynn | 5.00% | 3,244,434 | $327.36M | Insider |
| Holdings A. Novo | 3.77% | 2,445,147 | $246.72M | Insider |
| Scott D. Sandell | 3.39% | 2,199,372 | $221.92M | Insider |
| Anthony A. Florence Jr. | 3.39% | 2,197,975 | $221.78M | Insider |